MRS. JONNA IRISH PASCUAL MULLARKEY ARNP
Prescription History 1992111421
Nurse Practitioner - Family in Pittsburgh, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. JONNA IRISH PASCUAL MULLARKEY ARNP, an active Family specialist practicing in Pittsburgh, PA. Our medical registry currently tracks 40 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,718 documented patient claims. Among these therapy options, the most frequently utilized medication is Ozempic, which accounts for 236 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| OzempicSemaglutide | 236 | $1,145.79▼ below PA avg | ▲ More than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 236 Medicare prescriptions for Ozempic, about 3.9 times the volume of the typical Pennsylvania prescriber of this medication (61). Medicare paid an average of $1,145.79 per fill, versus $1,230.71 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 292.2 30-Day Fills standardized to 30-day supplies 8,360 Days of Medication total across all patients in 2024 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 147 | $139.51 | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2024, this provider wrote 147 Medicare prescriptions for Lantus Solostar, about 3.1 times the volume of the typical Pennsylvania prescriber of this medication (47.5). Medicare paid an average of $139.51 per fill, versus $113.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 338.8 30-Day Fills standardized to 30-day supplies 10,113 Days of Medication total across all patients in 2024 | |||
| Levothyroxine Sodium | 142 | $12.94 | ≈ Typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 142 Medicare prescriptions for Levothyroxine Sodium, about 81% of the volume of the typical Pennsylvania prescriber of this medication (174.6). Medicare paid an average of $12.94 per fill, versus $10.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 387.3 30-Day Fills standardized to 30-day supplies 11,593 Days of Medication total across all patients in 2024 | |||
| MounjaroTirzepatide | 122 | $1,181.50▼ below PA avg | ▲ More than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. An analog of GASTRIC INHIBITORY POLYPEPTIDE and agonist of GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR and GLUCAGON-LIKE PEPTIDE-1 RECEPTOR used to enhance glycemic control of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 122 Medicare prescriptions for Mounjaro, about 2.8 times the volume of the typical Pennsylvania prescriber of this medication (43.7). Medicare paid an average of $1,181.50 per fill, versus $1,230.18 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 141.8 30-Day Fills standardized to 30-day supplies 4,032 Days of Medication total across all patients in 2024 | |||
| JardianceEmpagliflozin | 92 | $1,008.34 | ▲ More than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure and kidney disease. It helps to lower the risk of death from heart disease and reduces the need of going to a hospital to treat heart failure or kidney disease. It also helps to lower the risk of dialysis in people with kidney disease. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2024, this provider wrote 92 Medicare prescriptions for Jardiance, about 1.5 times the volume of the typical Pennsylvania prescriber of this medication (60.8). Medicare paid an average of $1,008.34 per fill, versus $952.57 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 163.6 30-Day Fills standardized to 30-day supplies 4,903 Days of Medication total across all patients in 2024 | |||
| Metformin Hcl ErMetformin Hcl | 91 | $32.70 | ▲ More than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2024, this provider wrote 91 Medicare prescriptions for Metformin Hcl Er, about 1.5 times the volume of the typical Pennsylvania prescriber of this medication (59.3). Medicare paid an average of $32.70 per fill, versus $13.68 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 263.3 30-Day Fills standardized to 30-day supplies 7,900 Days of Medication total across all patients in 2024 | |||
| Humalog Kwikpen U-100Insulin Lispro | 83 | $252.48 | ▲ More than typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 83 Medicare prescriptions for Humalog Kwikpen U-100, about 2.4 times the volume of the typical Pennsylvania prescriber of this medication (34.8). Medicare paid an average of $252.48 per fill, versus $235.82 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 138.1 30-Day Fills standardized to 30-day supplies 4,006 Days of Medication total across all patients in 2024 | |||
| Metformin Hcl | 77 | $8.16▼ below PA avg | ▼ Less than typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2024, this provider wrote 77 Medicare prescriptions for Metformin Hcl, about 75% of the volume of the typical Pennsylvania prescriber of this medication (103.2). Medicare paid an average of $8.16 per fill, versus $8.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 193.3 30-Day Fills standardized to 30-day supplies 5,762 Days of Medication total across all patients in 2024 | |||
| TrulicityDulaglutide | 74 | $1,041.93▼ below PA avg | ▲ More than typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. A glucagon-like peptide-1 receptor agonist; GLP-1 immunoglobulin G (IgG4) Fc fusion protein with extended activity. In 2024, this provider wrote 74 Medicare prescriptions for Trulicity, about 1.7 times the volume of the typical Pennsylvania prescriber of this medication (44.4). Medicare paid an average of $1,041.93 per fill, versus $1,180.94 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 82.3 30-Day Fills standardized to 30-day supplies 2,332 Days of Medication total across all patients in 2024 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 65 | $141.30 | ▲ More than typical |
In 2024, this provider wrote 65 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 1.9 times the volume of the typical Pennsylvania prescriber of this medication (34.5). Medicare paid an average of $141.30 per fill, versus $92.24 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 158.1 30-Day Fills standardized to 30-day supplies 4,684 Days of Medication total across all patients in 2024 | |||
| SynthroidLevothyroxine Sodium | 53 | $65.55 | ≈ Typical |
About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 53 Medicare prescriptions for Synthroid, about the same volume as the typical Pennsylvania prescriber of this medication (46.5). Medicare paid an average of $65.55 per fill, versus $61.27 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 133.4 30-Day Fills standardized to 30-day supplies 3,977 Days of Medication total across all patients in 2024 | |||
| Novolog FlexpenInsulin Aspart | 39 | $364.94 | ≈ Typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2024, this provider wrote 39 Medicare prescriptions for Novolog Flexpen, about the same volume as the typical Pennsylvania prescriber of this medication (35.2). Medicare paid an average of $364.94 per fill, versus $227.65 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 73.5 30-Day Fills standardized to 30-day supplies 2,203 Days of Medication total across all patients in 2024 | |||
| Rosuvastatin Calcium | 33 | $13.38▼ below PA avg | ▼ Less than typical |
About Rosuvastatin Calcium: Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details. A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES. In 2024, this provider wrote 33 Medicare prescriptions for Rosuvastatin Calcium, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (124.4). Medicare paid an average of $13.38 per fill, versus $16.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 84.8 30-Day Fills standardized to 30-day supplies 2,540 Days of Medication total across all patients in 2024 | |||
| Atorvastatin Calcium | 29 | $15.95 | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2024, this provider wrote 29 Medicare prescriptions for Atorvastatin Calcium, about 13% of the volume of the typical Pennsylvania prescriber of this medication (216.6). Medicare paid an average of $15.95 per fill, versus $12.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63 30-Day Fills standardized to 30-day supplies 1,890 Days of Medication total across all patients in 2024 | |||
| Methimazole | 23 | $21.06 | ▼ Less than typical |
About Methimazole: Methimazole is used to treat overactive thyroid (hyperthyroidism). Show more ▾ It works by stopping the thyroid gland from making too much thyroid hormone. A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. In 2024, this provider wrote 23 Medicare prescriptions for Methimazole, about 62% of the volume of the typical Pennsylvania prescriber of this medication (37.1). Medicare paid an average of $21.06 per fill, versus $10.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 66.3 30-Day Fills standardized to 30-day supplies 1,988 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 23 | $14.94 | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 23 Medicare prescriptions for Gabapentin, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (100.2). Medicare paid an average of $14.94 per fill, versus $14.77 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2024 | |||
| Humulin R U-500 KwikpenInsulin Regular, Human | 23 | $2,171.66 | ≈ Typical |
About Humulin R U-500 Kwikpen: Concentrated insulin regular is used with a proper diet and exercise program to control high blood sugar in people with diabetes who require large doses of insulin (more than 200 units per day). Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It works right away like regular insulin but its effects last longer. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication may be used alone or with other oral diabetes drugs (such as metformin). Regular insulin preparations that contain the HUMAN insulin peptide sequence. In 2024, this provider wrote 23 Medicare prescriptions for Humulin R U-500 Kwikpen, about 85% of the volume of the typical Pennsylvania prescriber of this medication (27.1). Medicare paid an average of $2,171.66 per fill, versus $1,659.90 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35.7 30-Day Fills standardized to 30-day supplies 1,038 Days of Medication total across all patients in 2024 | |||
| Lisinopril | 22 | $3.13▼ below PA avg | ▼ Less than typical |
About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. In 2024, this provider wrote 22 Medicare prescriptions for Lisinopril, about 16% of the volume of the typical Pennsylvania prescriber of this medication (136). Medicare paid an average of $3.13 per fill, versus $7.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 44 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2024 | |||
| Calcitriol | 21 | $15.78▼ below PA avg | ▼ Less than typical |
About Calcitriol: Calcitriol is a man-made active form of vitamin D. Show more ▾ Most people get enough vitamin D from exposure to the sun and from fortified food products (such as dairy products, vitamins). Vitamin D helps control parathyroid hormone and the levels of certain minerals (such as calcium, phosphorus) that are needed for building and keeping strong bones. Before regular vitamin D can be used by the body, it needs to be changed to the active form by the liver and kidneys. Calcitriol is used in patients with kidney disease who can't make enough of the active form of Vitamin D. This medication is also used to prevent and treat certain types of calcium/phosphorus/parathyroid problems that can happen with long-term kidney dialysis or hypoparathyroidism. Calcitriol is usually used along with specific diet recommendations and sometimes other medications. The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. In 2024, this provider wrote 21 Medicare prescriptions for Calcitriol, about half the volume of the typical Pennsylvania prescriber of this medication (48.2). Medicare paid an average of $15.78 per fill, versus $16.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| Repaglinide | 21 | $65.79 | ▼ Less than typical |
About Repaglinide: Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. In 2024, this provider wrote 21 Medicare prescriptions for Repaglinide, about 64% of the volume of the typical Pennsylvania prescriber of this medication (32.9). Medicare paid an average of $65.79 per fill, versus $37.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2024 | |||
| Admelog SolostarInsulin Lispro | 20 | $256.04 | ≈ Typical |
About Admelog Solostar: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 20 Medicare prescriptions for Admelog Solostar, about the same volume as the typical Pennsylvania prescriber of this medication (20). Medicare paid an average of $256.04 per fill, versus $248.60 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.3 30-Day Fills standardized to 30-day supplies 786 Days of Medication total across all patients in 2024 | |||
| Repatha SureclickEvolocumab | 20 | $864.55 | ▼ Less than typical |
About Repatha Sureclick: Evolocumab is used along with a proper diet to help lower "bad" cholesterol (LDL) in the blood. Show more ▾ It may be used with other LDL-lowering treatments (such as "statin" drugs, ezetimibe, LDL apheresis). Evolocumab is also used by people who have heart disease to reduce the risk of heart attack, stroke, and certain types of chest pain that require treatment in a hospital. This medication belongs to a class of drugs known as monoclonal antibodies. It works by improving how well your body gets rid of LDL cholesterol. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. Targets PCSK9. In 2024, this provider wrote 20 Medicare prescriptions for Repatha Sureclick, about a third of the volume of the typical Pennsylvania prescriber of this medication (47.9). Medicare paid an average of $864.55 per fill, versus $806.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30.8 30-Day Fills standardized to 30-day supplies 896 Days of Medication total across all patients in 2024 | |||
| RybelsusSemaglutide | 20 | $1,750.46 | ≈ Typical |
About Rybelsus: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 20 Medicare prescriptions for Rybelsus, about 80% of the volume of the typical Pennsylvania prescriber of this medication (25). Medicare paid an average of $1,750.46 per fill, versus $1,332.80 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2024 | |||
| Glimepiride | 19 | $6.41▼ below PA avg | ▼ Less than typical |
About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. In 2024, this provider wrote 19 Medicare prescriptions for Glimepiride, about half the volume of the typical Pennsylvania prescriber of this medication (42.9). Medicare paid an average of $6.41 per fill, versus $11.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,530 Days of Medication total across all patients in 2024 | |||
| Ezetimibe | 19 | $36.02 | ▼ Less than typical |
About Ezetimibe: Ezetimibe is used along with a low cholesterol/low fat diet and exercise to help lower cholesterol in the blood. Show more ▾ Ezetimibe may be used alone or with other drugs (such as "statins" or fibrates). Ezetimibe works by reducing the amount of cholesterol your body absorbs from your diet. Reducing cholesterol may help prevent strokes and heart attacks. An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS. In 2024, this provider wrote 19 Medicare prescriptions for Ezetimibe, about a third of the volume of the typical Pennsylvania prescriber of this medication (54.7). Medicare paid an average of $36.02 per fill, versus $26.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2024 | |||
| Pioglitazone Hcl | 19 | $6.84▼ below PA avg | ▼ Less than typical |
About Pioglitazone Hcl: Pioglitazone is a diabetes drug (thiazolidinedione-type, also called "glitazones") used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Show more ▾ It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone. A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 19 Medicare prescriptions for Pioglitazone Hcl, about half the volume of the typical Pennsylvania prescriber of this medication (33.4). Medicare paid an average of $6.84 per fill, versus $16.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 29 30-Day Fills standardized to 30-day supplies 833 Days of Medication total across all patients in 2024 | |||
| LantusInsulin Glargine,hum.Rec.Anlog | 18 | $125.76 | ▼ Less than typical |
About Lantus: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2024, this provider wrote 18 Medicare prescriptions for Lantus, about 66% of the volume of the typical Pennsylvania prescriber of this medication (27.3). Medicare paid an average of $125.76 per fill, versus $100.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39.6 30-Day Fills standardized to 30-day supplies 1,176 Days of Medication total across all patients in 2024 | |||
| Droplet Pen NeedlePen Needle, Diabetic | 18 | $92.55 | ≈ Typical |
In 2024, this provider wrote 18 Medicare prescriptions for Droplet Pen Needle, about 88% of the volume of the typical Pennsylvania prescriber of this medication (20.3). Medicare paid an average of $92.55 per fill, versus $73.71 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2024 | |||
| HumalogInsulin Lispro | 18 | $230.22 | ▼ Less than typical |
About Humalog: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 18 Medicare prescriptions for Humalog, about 67% of the volume of the typical Pennsylvania prescriber of this medication (26.9). Medicare paid an average of $230.22 per fill, versus $191.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48.1 30-Day Fills standardized to 30-day supplies 1,442 Days of Medication total across all patients in 2024 | |||
| Insulin Lispro Kwikpen U-100Insulin Lispro | 14 | $223.76 | ▼ Less than typical |
About Insulin Lispro Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 14 Medicare prescriptions for Insulin Lispro Kwikpen U-100, about half the volume of the typical Pennsylvania prescriber of this medication (28.6). Medicare paid an average of $223.76 per fill, versus $156.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.7 30-Day Fills standardized to 30-day supplies 771 Days of Medication total across all patients in 2024 | |||
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,279.72 | ▼ Less than typical |
About Toujeo Max Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 14 Medicare prescriptions for Toujeo Max Solostar, about half the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $1,279.72 per fill, versus $1,070.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.7 30-Day Fills standardized to 30-day supplies 721 Days of Medication total across all patients in 2024 | |||
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $704.53 | ▼ Less than typical |
About Toujeo Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 12 Medicare prescriptions for Toujeo Solostar, about half the volume of the typical Pennsylvania prescriber of this medication (26.1). Medicare paid an average of $704.53 per fill, versus $681.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2024 | |||
| Unifine PentipsPen Needle, Diabetic | 12 | $43.35▼ below PA avg | ▼ Less than typical |
In 2024, this provider wrote 12 Medicare prescriptions for Unifine Pentips, about 63% of the volume of the typical Pennsylvania prescriber of this medication (19.1). Medicare paid an average of $43.35 per fill, versus $58.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 16.3 30-Day Fills standardized to 30-day supplies 475 Days of Medication total across all patients in 2024 | |||
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $1,542.47 | ▼ Less than typical |
About Synjardy Xr: This medication is a combination of 2 drugs: empagliflozin and metformin. Show more ▾ It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used to treat heart failure in people with type 2 diabetes. It helps to lower the risk of death from heart disease and reduces the need of going to a hospital to treat heart failure. This medication works by helping to restore your body's proper response to the insulin you naturally produce. It also increases the removal of sugar by your kidneys, decreases how much sugar is made in your liver, and decreases how much sugar your body takes in through your stomach and intestines. In 2024, this provider wrote 12 Medicare prescriptions for Synjardy Xr, about a third of the volume of the typical Pennsylvania prescriber of this medication (29.9). Medicare paid an average of $1,542.47 per fill, versus $942.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2024 | |||
| Humulin R U-500Insulin Regular, Human | 12 | $4,073.08 | ▼ Less than typical |
About Humulin R U-500: Concentrated insulin regular is used with a proper diet and exercise program to control high blood sugar in people with diabetes who require large doses of insulin (more than 200 units per day). Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It works right away like regular insulin but its effects last longer. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication may be used alone or with other oral diabetes drugs (such as metformin). Regular insulin preparations that contain the HUMAN insulin peptide sequence. In 2024, this provider wrote 12 Medicare prescriptions for Humulin R U-500, about 70% of the volume of the typical Pennsylvania prescriber of this medication (17.2). Medicare paid an average of $4,073.08 per fill, versus $2,214.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18.9 30-Day Fills standardized to 30-day supplies 567 Days of Medication total across all patients in 2024 | |||
| Hydrocortisone | 11 | $67.27 | ▼ Less than typical |
About Hydrocortisone: This medication is used to treat a variety of skin conditions (such as insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Show more ▾ Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2024, this provider wrote 11 Medicare prescriptions for Hydrocortisone, about a third of the volume of the typical Pennsylvania prescriber of this medication (30.5). Medicare paid an average of $67.27 per fill, versus $18.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 530 Days of Medication total across all patients in 2024 | |||
| TradjentaLinagliptin | 11 | $822.81 | ▼ Less than typical |
About Tradjenta: Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. In 2024, this provider wrote 11 Medicare prescriptions for Tradjenta, about a third of the volume of the typical Pennsylvania prescriber of this medication (33.6). Medicare paid an average of $822.81 per fill, versus $654.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2024 | |||
| Tresiba Flextouch U-100Insulin Degludec | 11 | $686.91 | ▼ Less than typical |
About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 11 Medicare prescriptions for Tresiba Flextouch U-100, about a third of the volume of the typical Pennsylvania prescriber of this medication (31.7). Medicare paid an average of $686.91 per fill, versus $646.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32.2 30-Day Fills standardized to 30-day supplies 966 Days of Medication total across all patients in 2024 | |||
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 11 | $53.74▼ below PA avg | ▼ Less than typical |
In 2024, this provider wrote 11 Medicare prescriptions for Ultra-Fine Nano Pen Needle, about half the volume of the typical Pennsylvania prescriber of this medication (23.4). Medicare paid an average of $53.74 per fill, versus $79.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 11.1 30-Day Fills standardized to 30-day supplies 283 Days of Medication total across all patients in 2024 | |||
| Acarbose | 11 | $20.64▼ below PA avg | ▼ Less than typical |
About Acarbose: Acarbose is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Acarbose works in your intestines to slow the breakdown and absorption of carbohydrates from foods that you eat. This effect helps lessen your blood sugar rise after a meal. An inhibitor of ALPHA-GLUCOSIDASES that retards the digestion and absorption of DIETARY CARBOHYDRATES in the SMALL INTESTINE. In 2024, this provider wrote 11 Medicare prescriptions for Acarbose, about half the volume of the typical Pennsylvania prescriber of this medication (19.7). Medicare paid an average of $20.64 per fill, versus $36.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 15 30-Day Fills standardized to 30-day supplies 447 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MRS. JONNA IRISH PASCUAL MULLARKEY ARNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Pittsburgh, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among PA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
